United Pharma IV Solutions has received three acquisition offers ranging between EGP 400 mn and 600 mn from Saudi and local investors, Al Borsa reports. According to chairman Abdallah Mahfouz, United Pharma is not looking to sell the company in its entirety, and is leaning towards expanding its shareholder base, while still maintaining the majority of shares.
More from Enterprise
Israel’s Arkia Airlines moves flights to Egypt’s Taba to bypass wartime airspace restrictions
Israel’s Arkia shifts some flights to Egypt as airspace tightens…
Miga guarantee unlocks USD 313 mn for National Bank of Egypt trade finance
Plus: Incolease taps securitization market with debut EGP 2 bn…
Private capital hasn’t frozen in MENA — but the exit playbook could change if the war drags on
PE and VC-backed companies were already pivoting to local exchanges…
Telda moves into investing with zero-fee stock trading
Telda claims users can sell a position and immediately spend…